Status report
Get it in writing
The official USPTO status record for XCELL AMNIO MATRIX, serial 88570895, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
XCELL AMNIO MATRIXSerial 88570895 · Principal Register
Dead · Withdrawn
Owner: Precise Bioscience
Class 005 - Pharmaceuticals
Filed Aug 08, 2019
The record shows that the mark “XCELL AMNIO MATRIX” is dead, having been abandoned by its owner, Precise Bioscience, a limited liability company organized in Illinois. The application was filed on August 8, 2019 on an intent‑to‑use basis for class 005, covering medical dressings. Because the mark is no longer active, it does not give the owner control over every use of the wording, but the record indicates that the closest concern would arise for any new mark that also claims rights to medical dressings or related pharmaceutical products. The prosecution history shows a straightforward abandonment sequence with no opposition or cancellation events, and the latest status event was the express abandonment mailed on January 21, 2020. No enforcement activity appears in the supplied history. For someone considering a similar name, the main risk is that the abandoned mark still shows a prior claim to medical dressings, so a new mark in that same category could face a closer record‑based concern.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.